Subpart H - [Effective2/25/2022]PAYMENT FOR END-STAGE RENAL DISEASE (ESRD) SERVICES
- Section 413.170 - [Effective2/25/2022]Scope
- Section 413.171 - [Effective2/25/2022]Definitions
- Section 413.172 - [Effective2/25/2022]Principles of prospective payment
- Section 413.174 - [Effective2/25/2022]Prospective rates for hospital-based and independent ESRD facilities
- Section 413.176 - [Effective2/25/2022]Amount of payments
- Section 413.177 - [Effective2/25/2022]Quality incentive program payment
- Section 413.178 - [Effective2/25/2022]ESRD quality incentive program
- Section 413.180 - [Effective2/25/2022]Procedures for requesting exceptions to payment rates
- Section 413.182 - [Effective2/25/2022]Criteria for approval of exception requests
- Section 413.184 - [Effective2/25/2022]Payment exception: Pediatric patient mix
- Section 413.186 - [Effective2/25/2022]Payment exception: Self-dialysis training costs in pediatric facilities
- Section 413.194 - [Effective2/25/2022]Appeals
- Section 413.195 - [Effective2/25/2022]Limitation on Review
- Section 413.196 - [Effective2/25/2022]Notification of changes in rate-setting methodologies and payment rates
- Section 413.198 - [Effective2/25/2022]Recordkeeping and cost reporting requirements for outpatient maintenance dialysis
- Section 413.200 - [Effective2/25/2022]Reserved
- Section 413.202 - [Effective2/25/2022]Organ procurement organization (OPO) cost for kidneys sent to foreign countries or transplanted in patients other than Medicare beneficiaries
- Section 413.203 - [Effective2/25/2022]Transplant center costs for organs sent to foreign countries or transplanted in patients other than Medicare beneficiaries
- Section 413.210 - [Effective2/25/2022]Conditions for payment under the end-stage renal disease (ESRD) prospective payment system
- Section 413.215 - [Effective2/25/2022]Basis of payment
- Section 413.217 - [Effective2/25/2022]Items and services included in the ESRD prospective payment system
- Section 413.220 - [Effective2/25/2022]Methodology for calculating the per-treatment base rate under the ESRD prospective payment system effective January 1, 2011
- Section 413.230 - [Effective2/25/2022]Determining the per treatment payment amount
- Section 413.231 - [Effective2/25/2022]Adjustment for wages
- Section 413.232 - [Effective2/25/2022]Low-volume adjustment
- Section 413.233 - [Effective2/25/2022]Rural facility adjustment
- Section 413.234 - [Effective2/25/2022]Drug designation process
- Section 413.235 - [Effective2/25/2022]Patient-level adjustments
- Section 413.236 - [Effective2/25/2022]Transitional add-on payment adjustment for new and innovative equipment and supplies
- Section 413.237 - [Effective2/25/2022]Outliers
- Section 413.239 - [Effective2/25/2022]Transition period
- Section 413.241 - [Effective2/25/2022]Pharmacy arrangements